Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.04
(
1.36%
)
Bitcoin
78,326.20
(
0.11%
)
News Focus
News Focus
Post# of 257438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

GrthzGd

Send PM Follow Ignore
Followers 15
Posts 1612
Boards Moderated 1
Alias Born 09/07/2010

GrthzGd

Re: delavida post# 175928

Wednesday, 03/26/2014 9:19:25 AM

Wednesday, March 26, 2014 9:19:25 AM

Post# of 257438

Turning to Endocyte's fundamentals, ... I wouldn't expect a major secondary offering to be forthcoming in the near-term

Whoops!

Endocyte launches 4.5M-share offering • 5:10 PM

Endocyte's (ECYT) offering would yield gross proceeds of $121.5M at current levels. Underwriters will have a 675K-share overallotment option. (PR)
The drug developer had $159M in cash/investments at the end of 2013, and no debt.
ECYT -0.7% AH
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today